Han Biomedical, Inc. engages in the manufacture, research and development of healthcare products for tissue repair and regeneration. Its products include BarriGel, HANBIO Patient Lubricant, HANCARE Collagen Matrix, HANBIO Gauze and LEOFOR Hyaluronic Acid Solution. The company was founded on September 22, 2009 and is headquartered in New Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company